BioSpace News Archive

Azura Ophthalmics Announces Participation at Upcoming Investor Conferences

Azura Ophthalmics Ltd. today announced that members of management will present at BTIG’s Ophthalmology Day 2022, being held on November 29, and at the Piper Sandler 34th Annual Healthcare Conference, being held from November 29 through December 1.

November 21, 2022
·
3 min read
Genetown

Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference

Thermo Fisher Scientific Inc. will present at the Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 10:30 a.m. (EST).

November 21, 2022
·
1 min read
Pharm Country

Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

Rocket Pharmaceuticals, Inc. today announces that Gaurav Shah, M.D., Chief Executive Officer, will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference.

November 21, 2022
·
4 min read
Biotech Bay

Verge Genomics to Present at Upcoming Investor Conferences in November

Verge Genomics announced today that Alice Zhang, CEO and co-founder of Verge Genomics, will present at both the Piper Sandler 34th Annual Healthcare Conference on November 29.

November 21, 2022
·
1 min read
Biotech Beach

Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Has No Clinically Significant Difference in Accuracy or Bias Between Black and White People

Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing.

November 21, 2022
·
10 min read
Scientific Study Shows Virtual Reality (VR) Use Improves Sperm Quality

Cryos International Sperm and Egg Bank today announced a published scientific study which suggests that the use of Virtual Reality (VR) headsets during sperm donation has a positive effect on sperm quality.

November 21, 2022
·
2 min read
Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Genmab A/S today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for subcutaneous epcoritamab (DuoBody®-CD3xCD20).

November 21, 2022
·
8 min read
Lone Star Bio

New Published Study Further Demonstrates the Ability of Natera’s mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of a new study in Nature Medicine, which shows that its mPCR technology is able to assess response to tebentafusp in treatment-refractory metastatic uveal melanoma.

November 21, 2022
·
3 min read
2San’s FDA Emergency Use Authorized Genabio® COVID-19 Rapid Self-Test Kit Now Available on Amazon Prime

2San announced today that the Genabio® COVID-19 Rapid Self-Test Kit, which received FDA Emergency Use Authorization this year1, is now available on Amazon.

November 21, 2022
·
5 min read
Lone Star Bio

HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022

Heart Test Laboratories, Inc. d/b/a HeartSciences today announced that Andrew Simpson, Chief Executive Officer of HeartSciences, will be participating at the at the 11th Annual Benchmark Discovery One-on-One Investor Conference.

November 21, 2022
·
3 min read